Clinical Trial Update: Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging [NA]

View source ↗

Summary

A longitudinal MRI trial using Helium-3 and Xenon-129 to study COPD and bronchiectasis is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis
• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Dr. Grace Parraga | Conditions: COPD, Bronchiectasis | NA | Status: RECRUITING